AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Consumer Spending, E-Commerce, and the Business of Lodging
Motley Fool Money
Biosimilars - What's Going on in the Market?
3min Snip
00:00
Summary
Transcript
Episode notes
The motley fool looks at the competitive landscape in farma and biote bio similars. Biologic humera, a medicine approved to treat symptoms of various inflammatory conditions, is the top drug in the industry by sales. Its 20 21 revenue reached 20 point seven billion dollars. And in 20 23, the drug faces an important patent cliff in the united states where the vast majority of its sales come from. For more on a new wave of bio similar drugs entering the market, here's olivia zitcos, high fools,. i'm on with keith spites, a health care analyst here at the motley fool.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode